Additionally, at pathway level, the concomitant activation of PI3K signaling pathway with FGF signaling (FGFR2 and FGFR3) or with NRF2-mediated oxidative response has also been identified in several tumor types [16]. This evidence concerns the gene PIK3CA and neoplasm.